Continuous versus intermittent short-acting β2-agonists nebulization as first-line therapy in hospitalized children with severe asthma exacerbation: a propensity score matching analysis.
Prapasri KulalertDumnoensun PruksakornJayanton PatumanondChutima SmathakaneeWantida ChuenjitSira NanthapisalPublished in: Asthma research and practice (2020)
Continuous SABA nebulization was more efficient than intermittent nebulization in the treatment of children with severe asthma exacerbation.